2 Result(s)

Article

Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper… in Diabetologia (2011)

Article

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a serum potassium change on renal outcomes in patients with type 2 diabetes and nephropathy.

Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper… in Diabetologia (2011)